4.6 Article

Fabrication of Nanoformulation Containing Carvedilol and Silk Protein Sericin against Doxorubicin Induced Cardiac Damage in Rats

Related references

Note: Only part of the references are listed.
Article

PREPARATION, CHARACTERIZATION AND SAFETY ASSESSMENT OF COMBINATORIAL NANOPARTICLES OF CARVEDILOL AND SERICIN

MOHAMMAD SHARIQ et al.

International Journal of Applied Pharmaceutics (2022)

Article Biology

Effectual Endeavors of Silk Protein Sericin against Isoproterenol Induced Cardiac Toxicity and Hypertrophy in Wistar Rats

Farogh Ahsan et al.

Summary: The research evaluated the effect of sericin on myocardial necrosis and hypertrophy, and found that sericin has significant cardioprotective effects.

LIFE-BASEL (2022)

Review Medicine, Research & Experimental

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management

Pushkar Singh Rawat et al.

Summary: Doxorubicin, a commonly used anti-cancer drug, exerts its activity through DNA intercalation and inhibition of topoisomerase II enzyme. However, its use is limited by its dose-dependent cardiotoxicity, which is believed to involve oxidative stress, apoptosis, and various other mechanisms. Pharmacological strategies have been explored to mitigate Doxorubicin-induced cardiotoxicity.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Engineering, Biomedical

Cardiovascular disease models: A game changing paradigm in drug discovery and screening

Houman Savoji et al.

BIOMATERIALS (2019)

Article Public, Environmental & Occupational Health

Determinants of cardiovascular disease and sequential decision-making for treatment among women: A Heckman's approach

Raman Mishra et al.

SSM-POPULATION HEALTH (2019)

Article Chemistry, Medicinal

An Insight on Silk Protein Sericin: From Processing to Biomedical Application

Farogh Ahsan et al.

DRUG RESEARCH (2018)

Review Pharmacology & Pharmacy

Insects: an underrepresented resource for the discovery of biologically active natural products

Lauren Seabrooks et al.

ACTA PHARMACEUTICA SINICA B (2017)

Article Medicine, Research & Experimental

Chlorogenic acid ameliorates isoproterenol-induced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes

Palaniyandi Akila et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Medicine, Research & Experimental

Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis

Mostafa Samak et al.

MEDICAL SCIENCE MONITOR BASIC RESEARCH (2016)

Review Pharmacology & Pharmacy

Mesoporous silica nanoparticles in medicine-Recent advances

Veronika Mamaeva et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Article Biochemistry & Molecular Biology

Histopathological Evaluation of Heart Toxicity of a Novel Selective PPAR-γ Agonists CKD-501 in db/db Mice

Hyun-Il Yang et al.

BIOMOLECULES & THERAPEUTICS (2013)

Article Materials Science, Multidisciplinary

The fascinating world of nanoparticle research

Florian J. Heiligtag et al.

MATERIALS TODAY (2013)

Review Cardiac & Cardiovascular Systems

The pathophysiology of heart failure

Clinton D. Kemp et al.

CARDIOVASCULAR PATHOLOGY (2012)

Article Nutrition & Dietetics

Selenium: Biochemical Role As A Component Of Glutathione Peroxidasec

J.T. Rotruck et al.

NUTRITION REVIEWS (2010)

Article Biochemistry & Molecular Biology

Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats

Lakshmanan Vennila et al.

REDOX REPORT (2010)

Article Cardiac & Cardiovascular Systems

Isomers (oleanolic and ursolic acids) differ in their protective effect against isoproterenol-induced myocardial ischemia in rats

S. Senthil et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)

Article Pharmacology & Pharmacy

Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats

KHS Farvin et al.

PHARMACOLOGICAL RESEARCH (2004)

Review Cardiac & Cardiovascular Systems

Cardiovascular complications of cancer therapy - Diagnosis, pathogenesis, and management

ETH Yeh et al.

CIRCULATION (2004)

Review Cardiac & Cardiovascular Systems

Desmin cytoskeleton: A potential regulator of muscle mitochondrial behavior and function

Y Capetanaki

TRENDS IN CARDIOVASCULAR MEDICINE (2002)